Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Halabi, Susan"'
Autor:
George DJ; Duke Cancer Institute, Duke University Medical Center, Durham, North Carolina, USA daniel.george@duke.edu., Hessel C; Exelixis, Inc., Alameda, California, USA., Halabi S; Alliance Statistics and Data Center, and Department of Biostatistics and Bioinformatics, Duke University, Durham, North Carolina, USA., Michaelson MD; Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA., Hahn O; Alliance Protocol Operations Office, Chicago, Illinois, USA., Walsh M; Dana-Farber/Partners CancerCare, Boston, Massachusetts, USA., Picus J; Siteman Cancer Center, Washington University School of Medicine, St. Louis, Missouri, USA., Small EJ; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, USA., Dakhil S; University of Kansas - Wichita, Wichita, Kansas, USA., Feldman DR; Memorial Sloan Kettering Cancer Center, New York, New York, USA., Mangeshkar M; Exelixis, Inc., Alameda, California, USA., Scheffold C; Exelixis, Inc., Alameda, California, USA., Morris MJ; Memorial Sloan Kettering Cancer Center, New York, New York, USA., Choueiri TK; Dana-Farber/Partners CancerCare, Boston, Massachusetts, USA.
Publikováno v:
The oncologist [Oncologist] 2019 Nov; Vol. 24 (11), pp. 1497-1501. Date of Electronic Publication: 2019 Aug 09.
Autor:
Halabi S; Department of Biostatistics and Bioinformatics, Duke University, Alliance Statistical and Data Center, Duke University, Durham, North Carolina., Rini BI; Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio., Escudier B; Department of Cancer Medicine, Institut Gustave Roussy, Villejuif, France., Stadler WM; Department of Medicine, University of Chicago Medical Center, Chicago, Illinois., Small EJ; Department of Urology, University of California at San Francisco, San Francisco, California.
Publikováno v:
Cancer [Cancer] 2015 Jun 01; Vol. 121 (11), pp. 1906. Date of Electronic Publication: 2015 Feb 11.
Autor:
Halabi S; Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, North Carolina; Alliance Statistical and Data Center, Duke University, Durham, North Carolina., Rini B, Escudier B, Stadler WM, Small EJ
Publikováno v:
Cancer [Cancer] 2014 Jan 01; Vol. 120 (1), pp. 52-60. Date of Electronic Publication: 2013 Oct 08.
Autor:
Apolo AB; Genitourinary Oncology Service, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10065, USA., Ostrovnaya I, Halabi S, Iasonos A, Philips GK, Rosenberg JE, Riches J, Small EJ, Milowsky MI, Bajorin DF
Publikováno v:
Journal of the National Cancer Institute [J Natl Cancer Inst] 2013 Apr 03; Vol. 105 (7), pp. 499-503. Date of Electronic Publication: 2013 Feb 14.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2010 Nov 20; Vol. 28 (33), pp. e692-3; author reply e694. Date of Electronic Publication: 2010 Oct 12.
Autor:
Rini BI; Department of Solid Tumor Oncology, Cleveland Clinic Taussig Cancer Institute, 9500 Euclid Ave/Desk R35, Cleveland, OH 44195, USA. rinib2@ccf.org, Halabi S, Rosenberg JE, Stadler WM, Vaena DA, Archer L, Atkins JN, Picus J, Czaykowski P, Dutcher J, Small EJ
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2010 May 01; Vol. 28 (13), pp. 2137-43. Date of Electronic Publication: 2010 Apr 05.
Autor:
Stadler WM; Section of Hematology/Oncology, Department of Medicine, University of Chicago Medical Center, Chicago, Illinois 60637, USA. wstadler@medicine.bsd.uchicago.edu, Halabi S, Rini B, Ernstoff MS, Davila E, Picus J, Barrier R, Small EJ
Publikováno v:
Cancer [Cancer] 2006 Sep 15; Vol. 107 (6), pp. 1273-9.
Publikováno v:
Cancer, vol 120, iss 1
BackgroundThe current study was conducted to investigate the dependence between progression-free survival (PFS) and overall survival (OS) in patients with metastatic renal cell carcinoma (mRCC) and to explore whether PFS can be used as an intermediat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______325::d68a7b652734ed6424acad6804ab10d8
https://escholarship.org/uc/item/7652n3vw
https://escholarship.org/uc/item/7652n3vw
Autor:
Apolo, Andrea B, Ostrovnaya, Irina, Halabi, Susan, Iasonos, Alexia, Philips, George K, Rosenberg, Jonathan E, Riches, Jamie, Small, Eric J, Milowsky, Matthew I, Bajorin, Dean F
Publikováno v:
Journal of the National Cancer Institute, vol 105, iss 7
A prognostic model that predicts overall survival (OS) for metastatic urothelial cancer (MetUC) patients treated with cisplatin-based chemotherapy was developed, validated, and compared with a commonly used Memorial Sloan-Kettering Cancer Center (MSK
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______325::e32f6fdfe44c1656c36432154db32070
https://escholarship.org/uc/item/2nz9d4z5
https://escholarship.org/uc/item/2nz9d4z5
Publikováno v:
Cancer. 120(1)
The current study was conducted to investigate the dependence between progression-free survival (PFS) and overall survival (OS) in patients with metastatic renal cell carcinoma (mRCC) and to explore whether PFS can be used as an intermediate endpoint